The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response by STAUDIGL, Michael, GERSTING, Soren W, DANECKA, Marta K, MESSING, Dunja D, WOIDY, Mathias, PINKAS, Daniel, KEMTER, Kristina F, BLAU, Nenad, MUNTAU, Ania C

Get full text

Loss of Function in Phenylketonuria is Caused by Impaired Molecular Motions and Conformational Instability by Gersting, S W, Kemter, K F, Staudigl, M, Messing, D D, Danecka, M K, Lagler, F B, Sommerhoff, C P, Roscher, A A, Muntau, A C

Get full text

Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations by Wu, Chenglin, de Miranda, Noel Fcc, Chen, Longyun, Wasik, Agata M, Mansouri, Larry, Jurczak, Wojciech, Galazka, Krystyna, Dlugosz-Danecka, Monika, Machaczka, Maciej, Zhang, Huilai, Peng, Roujun, Morin, Ryan D, Rosenquist, Richard, Sander, Birgitta, Pan-Hammarström, Qiang

Get full text

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma by Wang, Michael, Rule, Simon, Zinzani, Pier Luigi, Goy, Andre, Casasnovas, Olivier, Smith, Stephen D., Damaj, Gandhi, Doorduijn, Jeanette K., Lamy, Thierry, Morschhauser, Franck, Panizo, Carlos, Shah, Bijal, Davies, Andrew, Eek, Richard, Dupuis, Jehan, Jacobsen, Eric, Kater, Arnon P., Le Gouill, Steven, Oberic, Lucie, Robak, Tadeusz, Jain, Preetesh, Frigault, Melanie M., Izumi, Raquel, Nguyen, Dorothy, Patel, Priti, Yin, Ming, Długosz-Danecka, Monika

Get full text

P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB by Le Gouill, S., Długosz‐Danecka, M., Rule, S., Luigi Zinzani, P., Goy, A., Smith, S. D., Doorduijn, J. K., Panizo, C., Shah, B., Davies, A., Eek, R., Jacobsen, E., Kater, A. P., Robak, T., Jain, P., Calvo, R., Yang, H., Wang, M.

Get full text

TG‐1701, A SELECTIVE BRUTON TYROSINE KINASE (BTK) INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH UBLITUXIMAB AND UMBRALISIB (U2) IN PATIENTS WITH B‐CELL MALIGNANCIES by Cheah, C. Y, Jurczak, W, Lasica, M, Wickham, N, Wróbel, T, Walewski, J, Yannakou, C. K, Cheung, S, Lewis, K. L, Długosz‐Danecka, M, Giannopoulos, K, Miskin, H. P, Tang, J.‐P, Normant, E, O'Connor, O. A, Ricart, A. D, Tam, C. S

Get full text

ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY by Wang, M., Rule, S., Zinzani, P. L., Goy, A., Casasnovas, O., Smith, S. D., Damaj, G., Doorduijn, J. K., Lamy, T., Morschhauser, F., Panizo, C., Shah, B., Davies, A., Eek, R., Dupuis, J., Jacobsen, E., Kater, A. P., Le Gouill, S., Oberic, L., Robak, T., Jain, P., Calvo, R., Tao, L., Dlugosz‐Danecka, M.

Get full text

Long-Term Antibody Response to SARS-CoV-2 in Children by Dunay, Gabor A., Barroso, Madalena, Woidy, Mathias, Danecka, Marta K., Engels, Geraldine, Hermann, Katharina, Neumann, Friederike S., Paul, Kevin, Beime, Jan, Escherich, Gabriele, Fehse, Kristin, Grinstein, Lev, Haniel, Franziska, Haupt, Luka J., Hecher, Laura, Kehl, Torben, Kemen, Christoph, Kemper, Markus J., Kobbe, Robin, Kohl, Aloisa, Klokow, Thomas, Nörz, Dominik, Olfe, Jakob, Schlenker, Friderike, Schmiesing, Jessica, Schrum, Johanna, Sibbertsen, Freya, Stock, Philippe, Tiede, Stephan, Vettorazzi, Eik, Zazara, Dimitra E., Zapf, Antonia, Lütgehetmann, Marc, Oh, Jun, Mir, Thomas S., Muntau, Ania C., Gersting, Søren W.

Get full text

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study by Pula, Bartosz, Iskierka-Jazdzewska, Elzbieta, Dlugosz-Danecka, Monika, Szymczyk, Agnieszka, Hus, Marek, Szeremet, Agnieszka, Drozd-Sokolowska, Joanna, Waszczuk-Gajda, Anna, Zaucha, Jan M, Holojda, Jadwiga, Piszczek, Weronika, Steckiewicz, Pawel, Wojciechowska, Malgorzata, Osowiecki, Michal, Knopinska-Posluszny, Wanda, Dudzinski, Marek, Zawirska, Daria, Subocz, Edyta, Halka, Janusz, Pluta, Andrzej, Wichary, Ryszard, Kumiega, Beata, Budziszewska, Bozena K, Jurczak, Wojciech, Lech-Maranda, Ewa, Giannopoulos, Krzysztof, Robak, Tadeusz, Jamroziak, Krzysztof

Get full text

Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial by Radford, John, Connors, Joseph M., Younes, Anas, Gallamini, Andrea, Ansell, Stephen M., Kim, Won Seog, Gopal, Ajay K., Kaminski, Mark S, Cheong, June Won, Flinn, Ian W., Kalakonda, Nagesh, Pettengell, Ruth, Dlugosz-Danecka, Monika, Engley, Gerald, Fenton, Keenan, Liu, Rachael, Purevjal, Indra, Miao, Harry, Gautam, Ashish, Kuruvilla, John

Get full text

S820 FRONTLINE BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE 3/4 CLASSICAL HODGKIN LYMPHOMA: 3‐YEAR UPDATE OF THE ECHELON‐1 STUDY by Gallamini, A., Straus, D., Dlugosz‐Danecka, M., Alekseev, S., Illes, A., Picardi, M., Lech‐Maranda, E., Feldman, T., Smolewski, P., Savage, K., Bartlett, N., Walewski, J., Ramchandren, R., Zinzani, P., Connors, J., Jolin, H., Liu, R., Fenton, K., Josephson, N., Radford, J.

Request full text